Privia Health Group, Inc. (NASDAQ:PRVA) CEO Parth Mehrotra Sells 12,219 Shares

Privia Health Group, Inc. (NASDAQ:PRVA) CEO Parth Mehrotra sold 12,219 shares of the stock in a transaction on Tuesday, April 30th. The stock was sold at an average price of $18.42, for a total value of $225,073.98. Following the transaction, the chief executive officer now owns 261,640 shares of the company’s stock, valued at $4,819,408.80. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

Privia Health Group Stock Up 2.1 %

NASDAQ:PRVA traded up $0.38 during mid-day trading on Thursday, reaching $18.41. 782,205 shares of the stock were exchanged, compared to its average volume of 940,409. The company has a 50 day simple moving average of $19.67 and a 200-day simple moving average of $21.16. Privia Health Group, Inc. has a 1 year low of $17.54 and a 1 year high of $30.15. The stock has a market capitalization of $2.18 billion, a P/E ratio of 96.90, a P/E/G ratio of 2.51 and a beta of 0.81.

Privia Health Group (NASDAQ:PRVA) last announced its earnings results on Tuesday, February 27th. The company reported $0.02 earnings per share for the quarter, missing the consensus estimate of $0.04 by ($0.02). Privia Health Group had a net margin of 1.39% and a return on equity of 3.97%. The company had revenue of $440.80 million during the quarter, compared to analysts’ expectations of $425.81 million. During the same quarter last year, the business posted $0.14 earnings per share. The company’s revenue for the quarter was up 21.0% compared to the same quarter last year. As a group, research analysts predict that Privia Health Group, Inc. will post 0.26 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on PRVA shares. JPMorgan Chase & Co. decreased their target price on Privia Health Group from $38.00 to $30.00 and set an “overweight” rating on the stock in a research note on Wednesday, March 6th. Truist Financial decreased their target price on Privia Health Group from $32.00 to $28.00 and set a “buy” rating on the stock in a research note on Thursday, February 29th. TD Cowen decreased their target price on Privia Health Group from $30.00 to $26.00 and set an “outperform” rating on the stock in a research note on Friday, March 1st. Bank of America lowered Privia Health Group from a “buy” rating to a “neutral” rating and decreased their target price for the stock from $27.00 to $21.00 in a research note on Thursday, February 22nd. Finally, Stifel Nicolaus decreased their target price on Privia Health Group from $28.00 to $24.00 and set a “buy” rating on the stock in a research note on Wednesday. Two analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $27.62.

Institutional Trading of Privia Health Group

Institutional investors have recently modified their holdings of the business. Park Place Capital Corp boosted its stake in shares of Privia Health Group by 115.4% in the first quarter. Park Place Capital Corp now owns 2,492 shares of the company’s stock valued at $49,000 after buying an additional 1,335 shares in the last quarter. Benjamin Edwards Inc. boosted its stake in shares of Privia Health Group by 44.9% in the fourth quarter. Benjamin Edwards Inc. now owns 3,239 shares of the company’s stock valued at $75,000 after buying an additional 1,003 shares in the last quarter. Covestor Ltd boosted its stake in shares of Privia Health Group by 8.3% in the third quarter. Covestor Ltd now owns 6,703 shares of the company’s stock valued at $154,000 after buying an additional 514 shares in the last quarter. Benjamin F. Edwards & Company Inc. acquired a new position in Privia Health Group during the fourth quarter worth $158,000. Finally, International Assets Investment Management LLC raised its holdings in Privia Health Group by 2,721.7% during the fourth quarter. International Assets Investment Management LLC now owns 7,139 shares of the company’s stock worth $164,000 after purchasing an additional 6,886 shares during the last quarter. 94.48% of the stock is currently owned by hedge funds and other institutional investors.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.